BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 36498588)

  • 21. The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease.
    Mauermann ML
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):153-163. PubMed ID: 29157616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the POEMS syndrome.
    Kim YR
    Blood Res; 2022 Apr; 57(S1):27-31. PubMed ID: 35483922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. POEMS Syndrome.
    Dispenzieri A
    Hematology Am Soc Hematol Educ Program; 2005; ():360-7. PubMed ID: 16304404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs.
    Marsh ES; Keddie S; Terris-Prestholt F; D'Sa S; Lunn MP
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):172-176. PubMed ID: 33106368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POEMS Syndrome - A Diagnostic Dilemma with Challenging Presentation.
    Oyenuga M; Mohamed MMG; Patel R; Sartaj S; Sen S; Lacasse A; Kumar V
    J Community Hosp Intern Med Perspect; 2022; 12(6):69-72. PubMed ID: 36816171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
    Dispenzieri A; Lacy MQ; Hayman SR; Kumar SK; Buadi F; Dingli D; Litzow MR; Gastineau DA; Inwards DJ; Elliott MA; Micallef IN; Ansell SM; Hogan WJ; Porrata LF; Johnston PA; Afessa B; Bryce A; Kyle RA; Gertz MA
    Eur J Haematol; 2008 May; 80(5):397-406. PubMed ID: 18221391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.
    Naddaf E; Dispenzieri A; Mandrekar J; Mauermann ML
    Muscle Nerve; 2015 Oct; 52(4):658-9. PubMed ID: 26179010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
    Misawa S
    Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
    Kamezaki K; Nagafuji K
    Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposal of new clinical diagnostic criteria for POEMS syndrome.
    Suichi T; Misawa S; Sato Y; Beppu M; Sakaida E; Sekiguchi Y; Shibuya K; Watanabe K; Amino H; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):133-137. PubMed ID: 30279213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. POEMS syndrome.
    Dispenzieri A
    Blood Rev; 2007 Nov; 21(6):285-99. PubMed ID: 17850941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of POEMS syndrome.
    Dispenzieri A; Gertz MA
    Curr Treat Options Oncol; 2004 Jun; 5(3):249-57. PubMed ID: 15115653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. POEMS Syndrome: Diagnosis and Investigative Work-up.
    Dispenzieri A; Kourelis T; Buadi F
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):119-139. PubMed ID: 29157614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of POEMS syndrome after an initial manifestation of solitary plasmacytoma.
    Shindo M; Sato K; Yamamoto M; Toki Y; Hatayama M; Ito S; Ichiki K; Okamura N; Hosoki T; Ikuta K; Inamura J; Watanabe S; Torimoto Y; Kohgo Y
    Int J Hematol; 2011 Jun; 93(6):815-821. PubMed ID: 21553018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. POEMS Syndrome: Therapeutic Options.
    Jaccard A
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
    Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
    Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.
    Taenaka R; Shimokawa S; Katayama A; Nagao T; Obara T; Nishimura N; Tsujimoto A; Kohno K; Aoki K; Ogawa R
    J Med Case Rep; 2022 Aug; 16(1):311. PubMed ID: 35978379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. POEMS syndrome.
    Nyunt WWT; Remli R; Abdul Muttlib FA; Leong CF; Masir N; Tumian NR; Abdul Wahid SFS
    Malays J Pathol; 2017 Dec; 39(3):297-303. PubMed ID: 29279594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
    Ishii Y; Yamazaki E; Ishiyama Y; Yamamoto E; Hattori Y; Hagihara M; Tomita N; Ishigatsubo Y
    Int J Hematol; 2013 Dec; 98(6):723-8. PubMed ID: 24166587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.